Trial intelligence / Profile preview

Exercise and PRP vs Exercise Alone in Knee Osteoarthritis

NCT04697667Completed

Sponsor
Istanbul University-Cerrahpaşa
Start
Jan 2021
Primary completion
Jan 2022
Modality
Adoptive Cell Transfer
Countries
1
01

Overview

Randomised trial of autologous platelet-rich plasma in knee osteoarthritis (OA) (3 arms), sponsored by Istanbul University-Cerrahpaşa. Primary endpoints: Pain intensity at 3 months, Function at 3 months and 2 more. Started Jan 2021; status: completed.

02

Drugs

autologous platelet-rich plasma
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT04697667.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04697667.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call